Change to the Roche corporate executive committee

Wednesday, January 16, 2013 10:53 AM

Switzerland-based Roche has named John C. Reed, M.D., Ph.D., as its new head of Roche Pharma Research and Early Development (pRED) and member of the enlarged corporate executive committee.

Reed will be based in Basel and assume his new role on April 2, 2013. The Genentech Research and Early Development organization (gRED), based in South San Francisco, Calif., will not affected by this management change.

Prior to joining Roche, Reed served as CEO at Sanford-Burnham Medical Research Institute in La Jolla, Calif. He is a biomedical researcher with a focus on cancer, neuroprotection, autoimmunity and other diseases. Reed is an inventor of more than one hundred patents, a member of multiple scientific journal editorial boards and the founder or co-founder of a number of biotechnology companies. He has also served on the boards of directors of several public biopharmaceutical and biotechnology companies.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs